Intellectual Property Rights in Pharmaceutical Test Data : Origins, Globalisation and Impact
This book considers the intellectual property protection of clinical test data that has been submitted to governments, in particular through test data exclusivity rights. It focuses on how these intellectual property rights first emerged in the early 1980s, how they have globalised over the past fou...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Livre numérique |
| Sprache: | Anglais |
| Veröffentlicht: |
Cham :
Springer International Publishing
2023.
Cham : Springer Nature |
| Online Zugang: | Accès sur la plateforme Springer Accès sur la plateforme ISTEX Accès Université d'Orléans |
| Anmerkung: |
Springer e-books droit et criminologie (Licence nationale) |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Intellectual property rights in pharmaceutical test data, origins, globalisation and impact, Adam Buick, 2023, Cham, Switzerland, Springer Nature Switzerland AG, 1 vol. 227 p., 3-031-29435-1 • Intellectual Property Rights in Pharmaceutical Test Data, Texte imprimé, 9783031294372 • Intellectual Property Rights in Pharmaceutical Test Data, Texte imprimé, 9783031294389 |
Inhaltsangabe:
- Chapter 1 Introduction
- Chapter 2 An overview of the protection of submitted test data
- Chapter 3 The origins of test data exclusivity
- Chapter 4 The protection of submitted test data and the TRIPS Agreement
- Chapter 5 The globalisation of test data exclusivity
- Chapter 6 Approaches to the Implementation of the Protection of Submitted Test Data
- Chapter 7 The impact of test data exclusivity
- Chapter 8 The Impact of Test Data Exclusivity on Measures for the Protection of Public Health
- Chapter 9 Conclusion.